Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Daebongls.Co.,Ltd.

Market Cap 9.21TCr 6.02Cr 5.22Cr 4.82Cr 4.51Cr 8.43Cr 576.48Cr 8.61Cr 57Cr 22Cr 277.88Cr 23Cr 22Cr 966.2Cr P/E Ratio 2024
20.1x
P/E Ratio 2025 13.5x
Enterprise Value 10TCr 6.8Cr 5.9Cr 5.44Cr 5.1Cr 9.53Cr 651.39Cr 9.73Cr 65Cr 25Cr 313.99Cr 26Cr 25Cr 1.09TCr EV / Sales 2024
1.35x
EV / Sales 2025 1.38x
Free-Float
47.83%
Yield 2024
0.37%
Yield 2025 -
15/05 Daebongls.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
23/03 Daebongls.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
14/11 Daebongls.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
06/11 Daebongls.Co.,Ltd. announces Annual dividend, payable on April 24, 2026 CI
14/25/14 Daebongls.Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
15/25/15 Daebongls.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
21/25/21 Daebongls.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/24/14 Daebongls.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
06/24/06 Daebongls.Co.,Ltd. announced that it has received KRW 30 billion in funding from Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Samsung Securities Co.,Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Lindeman Asia Investment Corporation ands another investor CI
04/24/04 Daebongls.Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Samsung Securities Co.,Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Lindeman Asia Investment Corporation and another investor CI
14/24/14 Daebongls.Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
16/24/16 Daebongls.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
20/24/20 Daebongls.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
1 day+0.85%
1 week-3.37%
Current month-6.94%
1 month-22.34%
3 months-20.48%
6 months-33.89%
Current year-28.67%
1 week 7,870
Extreme 7870
8,600
1 month 7,870
Extreme 7870
10,500
Current year 7,870
Extreme 7870
12,380
1 year 7,870
Extreme 7870
15,520
3 years 7,740
Extreme 7740
26,700
5 years 6,860
Extreme 6860
26,700
10 years 4,025
Extreme 4025
26,700
Manager TitleAgeSince
Chief Executive Officer 81 27/03/2013
Chief Executive Officer 54 10/05/2011
Corporate Officer/Principal 58 30/03/2021
Director TitleAgeSince
Director/Board Member 54 10/05/2011
Director/Board Member 81 27/03/2013
Director/Board Member 58 30/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%-3.37%-40.64%+4.01% 6.01Cr
+1.68%+2.54%+42.70%+159.11% 1,01300Cr
+0.42%+4.95%+54.23%+49.76% 57TCr
+0.14%+0.20%+17.70%+63.65% 40TCr
-0.37%+4.97%+21.24%+15.95% 32TCr
+0.85%+0.18%+24.50%+14.78% 28TCr
+2.10%+4.92%+25.30%+33.80% 27TCr
+3.73%+1.40%+20.09%+61.22% 18TCr
-0.19%-0.46%-45.32%-48.35% 19TCr
+3.33%-2.86%+14.80%+61.16% 15TCr
Average +1.23%+2.19%+13.46%+41.51% 33.89TCr
Weighted average by Cap. +1.11%+3.99%+29.27%+72.19%

Financials

2024 2025
Net sales 9.4TCr 6.14Cr 5.33Cr 4.91Cr 4.6Cr 8.6Cr 587.89Cr 8.78Cr 59Cr 23Cr 283.38Cr 23Cr 23Cr 985.33Cr 10TCr 6.67Cr 5.79Cr 5.34Cr 5Cr 9.34Cr 638.64Cr 9.54Cr 64Cr 25Cr 307.84Cr 25Cr 24Cr 1.07TCr
Net income 733.95Cr 47.96L 41.62L 38.37L 35.95L 67.17L 46Cr 68.57L 4.58Cr 1.77Cr 22Cr 1.8Cr 1.76Cr 77Cr 1.01TCr 65.73L 57.04L 52.58L 49.27L 92.05L 63Cr 93.97L 6.27Cr 2.43Cr 30Cr 2.47Cr 2.41Cr 105.49Cr
Net Debt -2.2TCr -1.44Cr -1.25Cr -1.15Cr -1.08Cr -2.02Cr -137.87Cr -2.06Cr -14Cr -5.32Cr -66Cr -5.41Cr -5.29Cr -231.08Cr 1.2TCr 78.24L 67.89L 62.58L 58.64L 1.1Cr 75Cr 1.12Cr 7.47Cr 2.89Cr 36Cr 2.94Cr 2.87Cr 125.56Cr
Logo Daebongls.Co.,Ltd.
DaebongLS Co Ltd is a Korea-based company primarily engaged in the manufacture of pharmaceutical and cosmetic ingredients. The Company operates its business through two segments. The Pharmaceutical Active Ingredient Business segment provides active pharmaceutical ingredients for respiratory treatments, hypertension treatments, and digestive system treatments. The Cosmetic Material Business segment manufactures and sells natural and functional cosmetic ingredients. In addition, the Company provides testing services for materials used on the skin and engages in real estate leasing business. The Company sells its products in domestic and overseas markets.
Employees
131
Date Price Change Volume
11/26/11 8,310.00 +0.85% 13,561
10/26/10 8,240.00 -0.24% 12,808
09/26/09 8,260.00 +3.90% 15,745
08/26/08 7,950.00 -6.14% 28,285
05/26/05 8,470.00 -0.47% 15,373
  1. Stock Market
  2. Stocks
  3. A078140 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!